awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q39255188-DA1F3022-244F-4EA2-9ABC-DF7DACE851D2
Q39255188-DA1F3022-244F-4EA2-9ABC-DF7DACE851D2
BestRank
Statement
http://www.wikidata.org/entity/statement/Q39255188-DA1F3022-244F-4EA2-9ABC-DF7DACE851D2
A consensus statement for the clinical use of the renal sodium-glucose co-transporter-2 inhibitor dapagliflozin in patients with type 2 diabetes mellitus.
P2860
Q39255188-DA1F3022-244F-4EA2-9ABC-DF7DACE851D2
BestRank
Statement
http://www.wikidata.org/entity/statement/Q39255188-DA1F3022-244F-4EA2-9ABC-DF7DACE851D2
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
81dfbfc70d7bc16256f9b65fccd6e204a59da213
P2860
Osmotic diuresis with SGLT2 inhibition: analysis of events related to volume reduction in dapagliflozin clinical trials.